Timepoint | Visit 1: Verbal consent and pre-baseline | Visits 1 and 2 may be combined Visit 2: Baseline (≤ 2 weeks prior to start of treatment) | Visit 3: Treatment | Visit 4: Post treatment (≤ 2 weeks after end of 8 weeks treatment period) | Visit 5: Long term follow-up (3 months post Visit 4 (± 4 weeks)) |
---|---|---|---|---|---|
Enrolment: | Â | Â | Â | Â | Â |
Eligibility screening (including medical history) | Â | X | Â | Â | Â |
Informed Consent | X verbal | X written | Â | Â | Â |
Randomisation | Â | X | Â | Â | Â |
Interventions: | Â | Â | Â | Â | Â |
CHAIN | Â | Â | X | Â | Â |
Standard care physiotherapy | Â | Â | X | Â | Â |
Assessments: | Â | Â | Â | Â | Â |
Primary outcome | Â | Â | Â | Â | Â |
 †HOOS (function, daily living) |  | X |  | X |  |
Secondary outcomes | Â | Â | Â | Â | Â |
 HOOS (function, daily living) |  | X |  |  | X |
 HOOS (other subscales) |  | X |  | X | X |
 ‡PAM |  | X |  | X | X |
 30-sec sit-stand test |  | X |  | X |  |
 Stair climb test |  | X |  | X |  |
 40 m walk test |  | X |  | X |  |
 §BMI, % body fat, ¶BP, |  | X |  | X |  |
 resting #HR |  |  |  |  |  |
 Analgesia Use (**RUQ) |  | X |  | X | X |
Other measures | Â | Â | Â | Â | Â |
 Psychological questionnaire and patient feedback (CHAIN arm only) |  |  |  | X |  |
 Interaction with CHAIN video content |  |  | X |  |  |
 Range of motion of hip |  | X |  | X |  |
 ††PSFS |  | X |  | X | X |
 Exercise Diary |  |  | X |  |  |
 Adverse Events |  | X | X | X |  |
Descriptive measures | Â | Â | Â | Â | Â |
 Age, gender, employment status, ethnicity, education |  | X |  |  |  |
Health economic data | Â | Â | Â | Â | Â |
 EQ-5D-5 L |  | X |  | X | X |
 RUQ |  | X |  | X | X |